About 200 reports

Global Anti Acne Cosmetics Sales Market Report 2017

120 pages • By QY Research

Notes: Sales, means the sales volume of Anti Acne Cosmetics Revenue, means the sales value of Anti Acne Cosmetics This report studies sales (consumption) of Anti Acne Cosmetics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue...

3 636 4 000 3 091
Feb 2017

Global Anti Acne Cosmetics Market Research Report 2017

102 pages • By QY Research

Notes: Production, means the output of Anti Acne Cosmetics Revenue, means the sales value of Anti Acne Cosmetics This report studies Anti Acne Cosmetics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production,...

2 636 2 900 2 241
Feb 2017

Global Atopic Dermatitis Drugs Market Research Report 2017

105 pages • By QY Research

Notes: Production, means the output of Atopic Dermatitis Drugs Revenue, means the sales value of Atopic Dermatitis Drugs This report studies Atopic Dermatitis Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity,...

2 636 2 900 2 241
Feb 2017

United States Atopic Dermatitis Treatment Market Report 2017

120 pages • By QY Research

Notes: Sales, means the sales volume of Atopic Dermatitis Treatment Revenue, means the sales value of Atopic Dermatitis Treatment This report studies sales (consumption) of Atopic Dermatitis Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering ...

3 455 3 800 2 936
Jan 2017

Global Atopic Dermatitis Drugs Market 2017-2021

68 pages • By Infiniti Research Limited

About Atopic Dermatitis Drugs Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever),...

3 398 3 500 2 922
Jan 2017

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2017

163 pages • By 9Dimen Research

Onychomycosis (Tinea Unguium) Drug Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan,...

2 591 2 850 2 202
Jan 2017

Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Contact Dermatitis Report is to understand the market and...

1 818 2 000 1 545
Jan 2017

Skin Infections-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Atopic Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Atopic Dermatitis Report is to understand the market and pipeline...

1 818 2 000 1 545
Jan 2017

Pruritus-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Pruritus-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Pruritus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 136 1 250 966
Jan 2017

Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Eczema Report is to understand the market and pipeline status of the...

1 818 2 000 1 545
Jan 2017

HIV-Associated Lipodystrophy Syndrome-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ HIV-Associated Lipodystrophy Syndrome-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the HIV-Associated Lipodystrophy Syndrome. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical,...

1 136 1 250 966
Jan 2017

Cellulitis-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pruritus Report is to understand the market and pipeline status of...

1 818 2 000 1 545
Jan 2017

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Genital Warts (Condylomata Acuminata)...

1 818 2 000 1 545
Jan 2017

Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dermatitis Report is to understand the market and pipeline status...

1 818 2 000 1 545
Jan 2017

Atopic Dermatitis-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

Lipodystrophy-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Lipodystrophy-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Lipodystrophy. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 136 1 250 966
Jan 2017

Atopic dermatitis (AD)- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Atopic dermatitis (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and...

4 500 4 950 3 825
Jan 2017

Atopic dermatitis (AD) - Epidemiology Forecast To 2023

By Delve Insight

DelveInsight “Atopic dermatitis (AD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Atopic dermatitis (AD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Atopic dermatitis (AD) prevalent or incident cases segmented...

2 500 2 750 2 125
Jan 2017

Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight

DelveInsight’s Report, “Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Urticaria Or Hives Report is to understand...

1 818 2 000 1 545
Jan 2017

Actinic (Solar) Keratosis-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain,...

4 500 4 950 3 825
Jan 2017

Cutaneous Mastocytosis-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Cutaneous Mastocytosis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Mastocytosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II,...

1 136 1 250 966
Jan 2017

Lichen Simplex Chronicus (Neurodermatitis)-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

Hirsutism-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Hirsutism-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hirsutism. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration....

1 136 1 250 966
Jan 2017

Actinic Keratosis-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Actinic Keratosis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Actinic Keratosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III...

1 136 1 250 966
Jan 2017

Inflammatory Skin Diseases-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Inflammatory Skin Diseases-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Inflammatory Skin Diseases. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase...

1 136 1 250 966
Jan 2017

Plaque Psoriasis (Psoriasis Vulgaris)-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

1 136 1 250 966
Jan 2017

Cutaneous Lupus Erythematosus-Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “ Cutaneous Lupus Erythematosus-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Lupus Erythematosus. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase...

1 136 1 250 966
Jan 2017